Tobacco smoke and the upper airway

Clinical Otolaryngology and Allied Sciences

Volumn 28, Issue 6, 2003, Pages 492-496

  Phillips, D E ^a,d   Hill, L ^a   Weller, P ^b   Willett, M ^c   Bakewell, R ^a  

^a SOUTH WARWICKSHIRE NHS FOUNDATION TRUST   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c Old Mill Surgery ^*  (United Kingdom)

^d WARWICK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SUBSTANCE P; TOBACCO SMOKE;

ALLERGY; BRONCHUS HYPERREACTIVITY; CAPILLARY PERMEABILITY; CIGARETTE SMOKING; CILIARY MOTILITY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; NOSE MUCOSA; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; REVIEW; UPPER RESPIRATORY TRACT;

AIRWAY RESISTANCE; HUMANS; MUCOCILIARY CLEARANCE; NASAL MUCOSA; PLANTS, TOXIC; SMOKE; SMOKING; TOBACCO;

EID: 0344944145     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.2003.00726.x     Document Type: Review

References (54)

1. THOMAS M., WALKER A. & WILMOT A. (1998) Office for National Statistics Living in Britain: Results From the 1996 General Household Survey. Stationary Office, London
2. PARROT S., GODFREY C. & RAW M. (1998) Guidance for commissioners on the cost-effectiveness of smoking cessation interventions. Thorax 53 (Suppl. 5), S1-S38
3. ASH BASIC FACTS NO. 2 (2000) Smoking and Disease. Action on Smoking and Health, February, 2000. Royal College of Physicians
4. PETO R., LOPEZ A.D., BOREHAM J. et al. (1992) Mortality from tobacco in developed countries: indirect estimation from vital statistics. Lancet 339, 1268-1278
5. PETO R., LOPEZ A.D., BOREHAM J. et al. (1994) Imperial Cancer Research Fund and World Health Organization. Mortality From Smoking in Developed Countries, 1950-2000. Oxford University Press, Oxford
6. TOBACCO ADVISORY GROUP (2000) Royal College of Physicians. Nicotine Addiction in Britain. RCP, London
7. DOLL R. & HILL A.B. (1950) Smoking and carcinoma of the lung. Preliminary report. BMJ ii, 739-748
8. DOLL R. & PETO R. (1976) Mortality in relation to smoking: 20 years' observations on male British doctors. BMJ ii, 1525-1536
9. DOLL R., PETO R., WHEATLEY K. et al. (1994) Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 309, 901-911
10. PETO R. (2000) Smoking, smoking cessation and lung cancer. BMJ 321, 323-329
11. DOLL R. (1996) Cancers weakly related to smoking. Br. Med. Bull. 52, 35-49
12. BOYLE P., MARSHALL J.R., MAISONNEUVE P. et al. (1998) Epidemiology of head and neck tumours. In Diseases Head, Neck; Nose and Throat, JONES A.S., PHILLIPS D.E. & HILGERS F. (eds), pp. 53-80. Arnold, London
13. SETHI J.M. & ROCHESTER C.L. (2000) Smoking and chronic obstructive pulmonary disease. Clinics Chest Med. 21, 67-86
14. US SURGEON-GENERAL (1984) The Health Consequences of Smoking: Chronic Obstructive Lung Disease. US Department of Health and Human Services, Washington, DC
15. MITCHELL R.I. (1962) Controlled measurement of smoke particle retention in the respiratory tract. Am. Rev. Respir. Dis. 85, 526-533
16. FERRON G.A. (1977) The size of soluble aerosol particles as a function of the humidity of the air. Applications to the human respiratory tract. J. Aerosol. Sci. 8, 251-267
17. TU K.U. & KNUDSON E.O. (1984) Total deposition of ultrafine hydrophobic and hygroscopic aerosols in the human respiratory tract. Aerosol. Sci. Technol. 3, 453-465
18. MYGIND N. & WIHL J.A. (1977) Scanning electron microscopy of a bacterial infection of the human nasal mucosa. Br. J. Dis. Chest 71, 259-267
19. AUERBACH O., STOUT A.P., HAMMOND E.C. et al. (1961) Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N. Engl. J. Med. 265, 253-267
20. INOUYE T., NAKANOBOH M., TANABE T. et al. (1999) Laser surgery for allergic and hypertrophic rhinitis. Ann. Otol. Rhinol. Laryngol. 108, S180 (No. 11 Part 2)
21. GLUCK U. & GEBBERS J.O. (2000) The comet assay of nasal epithelia: measurement of DNA damage for the assessment of genotoxic air pollution. Laryngoscope 110, 123-125
22. BASCOM R. (1991) The upper respiratory tract, mucus membrane irritation. Environ. Health Perspectives 95, 39-44
23. DESSI P., SAMBUC R., MOULIN G. et al. (1994) Effects of heavy smoking on nasal resistance. Acta Otolaryngol. (Stockholm) 114, 305-310
24. COLLINS M.M., HAWTHORNE M., EL-HMD K. et al. (1999) The subjective effects of smoking on nasal symptoms. Clin. Otolaryngol. 24, 324-327
25. CROSS S., WELLER P., BAKEWELL R. et al. (2000) A Prospective Study of the Association of Asthma and Rhinitis with Reference to Smoking Status and Symptom Pattern of Rhinitis. European Respiratory Society, Florence Italy (Abstract 819)
26. HOWARD T.D., POSTMA D.S., KOPPELMAN G.H. et al. (2002) Fine mapping of an IgE-controlling gene on chromosome 2q: analysis of CTLA4 and CD28. J. Allergy Clin. Immunol. 110, 743-751
27. DEMENAIS F. (on behalf of the EGEA Cooperative Group) (1998) The Genetic Component of Asthma, Bronchial Hyperresponsiveness and Atopy in the French EGEA Study. ENFUMOSA The European Network For Understanding Mechanisms of Severe Asthma (4th Quarterly meeting), Montpellier, France (Abstract)
28. RUTLAND J. & COLE P.J. (1981) Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared to sinusitis and bronchiectasis. Thorax 36, 654-658
29. STANLEY P.J., WILSON R., GREENSTONE M. et al. (1986) Effect of cigarette smoking on nasal mucociliary clearance and ciliary beat frequency. Thorax 41, 519-523
30. MAHAKIT P. & PUMHIRUN P. (1995) A preliminary study of nasal mucociliary clearance in smokers, sinusitis and allergic rhinitis patients. Asian Pacific J. Allergy Immunol. 13, 119-121
31. LUNDBERG J.M., LUNDBLAD L., SARIA A. et al. (1984) Inhibition of cigarette smoke-induced oedema in the nasal mucosa by capsaicin pre-treatment and a substance P antagonist. Naunyn-Schmiedebergs Arch. Pharmacol. 326, 181-185
32. LUNDBERG J.M., SARIA A. & MARTLING C.-R. (1983) Capsacin pre-treatment abolishes cigarette smoke-induced oedema in rat tracheobronchial mucosa. Eur. J. Pharmacol. 86, 317-318
33. GRIEFF L., WOLLMER P., ANDERRON M. et al. (1994) Human nasal absorption of 51 Cr-EDTA in smokers and control subjects. Clin. Exp. Allergy 24, 1036-1040
34. FISCHER J., DAHMEN K. & JACKOWSKI M. (1990) Effect of chronic inhaled pollutants (cigarette smoke) on transepithelial measured potential difference of nasal mucosa in the human. Pneumologie 44, 343-344
35. MELISKA C.J., STUNKARD M., GILBERT D. et al. (1995) Immune function in cigarette smokers who quit smoking for 31 days. J. Allergy Clin. Immunol. 95, 901-910
36. BURROWS B., HALONEN M., LEBOWITZ M.D. et al. (1982) The relationship of serum immunoglobulin E, allergy tests and smoking to respiratory disorders. J. Allergy Clin. Immunol. 70, 199-204
37. ZETTERSTROM O., OSTERMAN K., MACHADO L. et al. (1981) Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy. BMJ 283, 1215-1217
38. WARREN C.P.W., HOLDFORD STREVENS V. & WONG C. (1982) The relationship between smoking and total immunoglobulin E levels. J. Allergy Clin. Immunol. 69, 370-375
39. MAGNUSSEN C.G. (1986) Maternal smoking influences cord serum IgE and IgD levels and increases the risk for subsequent infant allergy. J. Allergy Clin. Immunol. 78, 898-904
40. KJELLMAN N.I.M. & CRONER S. (1984) Cord blood IgE determination for allergy production - a follow-up to 7 years of age in 1651 children. Ann. Allergy 53, 167-171
41. ZETTERSTROM O., NORDVALL S.L., BJORKSTEIN G. et al. (1985) Increased IgE antibody responses in rats exposed to tobacco smoke. J. Allergy Clin. Immunol. 75, 594-598
42. GERRARD J.W., HEINER D.C., Ko C.G. et al. (1980) Immunoglobulin levels in smokers and non-smokers. Ann. Allergy 44, 261-262
43. MORGAN D.C., SMYTH J.T., LISTER T.W. et al (1973) Chest symptoms and farmers lung, a community survey. Br. J. Ind. Med. 30, 259-265
44. WARREN C.P.W. (1977) Extrinsic allergic alveolitis, a disease commoner in non-smokers. Thorax 32, 567-569
45. NADEL J.A. (1992) Regulation of neurogenic inflammation by neutral endopeptidase. Ann. Rev. Respir. Dis. 145, 548-552
46. DEVILLIER P., DESSANGES J.F., RAKITOSIHANAKA J.F. et al. (1988) Nasal response to substance P and methacholine in subjects with and without allergic rhinitis. Eur. Respir. J. 1, 356-361
47. NIEBER K., BAUMGARTEN C., WITZEL A. et al. (1991) The possible role of substance P in the allergic reaction based on two different provocation models. Int. Arch. Allergy Appl. Immunol. 94, 334-338
48. JANESCO G., KIRALY E. & JANESCO-GABOR A. (1977) Pharmacologically induced selective degeneration of chemosensitive primary sensory neurons. Nature 270, 741-743
49. STJARNE P., LUNDBLAD L., LUNGBERG J.M. et al. (1989) Capsaicin and nicotine-sensitive neurones and nasal secretions in healthy human volunteers and patients with vasomotor rhinitis. Br. J. Pharmacol. 96, 693-701
50. MOXHAM J. (2000) Nicotine addiction. BMJ 320, 391-392
51. COOK D.G. & STRACHAN D.P. (1999) Health effects of passive smoking - summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax 54, 357-366
52. TURKELTAUB P.C. & GERGEN P.J. (1991) Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: dat from the second National Health and Nutrition Examination Survey 1976-1980 (NHANES II). Ann. Allergy 67 (2 Pt 1), 147-154
53. BRITTON J. & JARVIS M.J. (2000) Bupropion: a new treatment for smokers. BMJ 321, 65-66
54. JORENBY D.E., LEISCHOW S.J., NIDES M.A. et al. (1999) A controlled trial of sustained-release bupropion, a nicotine patch or both for smoking cessation. N. Engl. J. Med. 340, 685-691